• KR
  • EN
최근 검색어
닫기

교수찾아삼만리

총 게시물 1,226건, 최근 0 건
이전글  다음글  목록 글쓰기
Dr. 정재훈
Dr. Jung Jae Hoon
소속병원
삼성서울병원
진료과목
내분비대사내과
예약전화
02-3410-3000
전문분야
갑상선질환
조회수
514
추천의견
0
요일
오전
오후
월요일
진료가능
화요일
진료가능
수요일
진료가능
목요일
진료가능
금요일
토요일
학력
1999.08 서울대학교 의과대학원 의학과 (박사)
1995.02 서울대학교 의과대학원 의학과 (석사)
1985.02 서울대학교 의과대학 의학과 졸업 (의학사)
경력
2017.04 ~현재 성균관대학교 의과대학 내과학교실 주임교수
2017.04 ~현재 삼성서울병원 내과 과장
2007.10 ~현재 성균관대학교 의과대학 내과 교수
1994.05 ~현재 삼성서울병원 내분비-대사 내과 전문의
2013.08 ~ 2017.03 삼성서울병원 갑상선센터장
2011.11 ~ 2017.03 성균관의대 삼성서울병원 내분비-대사 내과 과장
2007.09 ~ 2011.10 삼성서울병원 진료의뢰센터 센터장
2005.05 ~ 2009.08 삼성서울병원 암센터 갑상선암팀장
2001.10 ~ 2007.09 성균관대학교 의과대학 내과 부교수
2001.01 ~ 2002.02 미국 오하이오 의과대학 방문연구원
1997.03 ~ 2001.09 성균관대학교 의과대학 내과 조교수
2000.02 ~ 2000.12 미국 국립보건원 (NIH) NIDDK 방문연구원
1996.08 내분비-대사 내과 분과전문의 자격 취득
1992.05 ~ 1994.04 서울대학교병원 내분비-대사 내과 전임의
1993.01 ~ 1993.04 미국 국립보건원 (NIH) NIDDK 방문연구원
1990.05 ~ 1992.04 공군 방공포병사령부 의무실장
1989.04 ~ 1990.04 육군 보병 제5사단 내과 군의관
1989.03 내과 전문의 자격 취득
1986.02 ~ 1989.02 서울대학교병원 내과 레지던트 과정 수료
1985.03 ~ 1986.02 서울대학교병원 인턴과정 수료
학회
2011.10 ~ 2015.08 대한갑상선학회 이사장
2013.01 ~ 2014.12 대한내분비학회 윤리이사
2008 ~ 2011 대한갑상선학회 기획이사
2004 ~ 2007 대한갑상선학회 총무
논문
SCI REP-UK 2019 10.1038/s41598-019-55370-w
Improved survival after early detection of asymptomatic distant metastasis in patients with thyroid cancer
Kim1, H; Park, SY; Jung, J; Kim, JH; Hahn, SY; Shin, JH; Oh, YL; Chung, MK; Kim, HI; Kim, SW; Chung, JH; Kim, TH

THYROID 2019 10.1089/thy.2019.0261
Multifocality in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma Is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis
Park1, J; Kim, JW; Park, H; Park, SY; Kim, TH; Kim, SW; Oh, YL; Chung, JH

THYROID 2019 10.1089/thy.2019.0246
Extended Real-World Observation of Patients Treated with Sorafenib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Impact of Lenvatinib Salvage Treatment: A Korean Multicenter Study
Oh1, HS; Shin, DY; Kim, M; Park, SY; Kim, TH; Kim, BH; Kim, EY; Kim, WB; Chung, JH; Shong, YK; Lim, DJ; Kim, WG

EUR J NUTR 2019 10.1007/s00394-018-1837-4
Non-immune-related hypothyroidism and its relationship with excess iodine
Kim1, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Han, JM; Bae, JC; Kim, SW; Kim, TH; Chung, JH

BJU INT 2019 10.1111/bju.14902
Effects of poloxamer-based thermo-sensitive sol-gel agent on urethral stricture after transurethral resection of the prostate for benign prostatic hyperplasia: a multicentre, single-blinded, randomised controlled trial
Chung1, JH; Kim, KS; Choi, JD; Kim, TH; Lee, KS; Oh, CY; Noh, JH; Kim, JS; Kim, WT; Lee, SH; Kim, JH; Kim, TN; Huh, W; Lee, SW

THYROID 2019 10.1089/thy.2018.0541
Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma
Kim1, HI; Hyeon, J; Park, SY; Ahn, HS; Kim, K; Han, JM; Bae, JC; Shin, JH; Kim, JS; Kim, SW; Chung, JH; Kim, TH; Oh, YL

INTERNATIONAL NEUROUROLOGY JOURNAL 2019 10.5213/inj.1938026.013
Effect of Nocturnal Hypoxia on Nocturia in Patients With Obstructive Sleep Apnea
Chung1, JH; Moon, HS; Park, SY; Kim, KR; Cho, SH; Kim, YT

ENDOCRINE 2019 10.1007/s12020-018-1807-x
Long-term outcomes of renal function after radioactive iodine therapy for thyroid cancer according to preparation method: thyroid hormone withdrawal vs. recombinant human thyrotropin
Cho1, YY; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Chung, JH; Kim, SW

ORAL ONCOL 2019 10.1016/j.oraloncology.2018.12.014
Refining the tumor-node-metastasis staging system for individualized treatment of differentiated thyroid carcinoma
Kim1, YN; Kim, M; Ahn, HS; Kim, K; Park, SY; Kim, HI; Jeon, MJ; Kim, WG; Kim, SW; Kim, WB; Chung, JH; Shong, YK; Kim, TY; Kim, TH

EUR J NUTR 2019 10.1007/s00394-017-1587-8
Urinary iodine concentration and thyroid hormones: Korea National Health and Nutrition Examination Survey 2013-2015
Kim1, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Kim, SW; Kim, TH; Chung, JH

ORAL ONCOL 2018 10.1016/j.oraloncology.2018.10.029
Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study
Kim1, M; Kim, HI; Jeon, MJ; Kim, HK; Kim, EH; Yi, HS; Kim, ES; Kim, H; Kim, BH; Kim, TY; Kim, SW; Kang, HC; Kim, WB; Chung, JH; Shong, YK; Kim, TH; Kim, WG

THYROID 2018 10.1089/thy.2018.0263
Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea
Oh1, HS; Ha, J; Kim, HI; Kim, TH; Kim, WG; Lim, DJ; Kim, TY; Kim, SW; Kim, WB; Shong, YK; Chung, JH; Baek, JH

J CLIN ENDOCR METAB 2018 10.1210/jc.2018-01386
Clinical Validation of the Prognostic Stage Groups of the Eighth-Edition TNM Staging for Medullary Thyroid Carcinoma
Park1, SY; Cho, YY; Kim, HI; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Kim, K; Kim, SW; Chung, JH; Kim, TH

ORAL ONCOL 2018 10.1016/j.oraloncology.2018.09.008
Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study
Kim1, M; Kim, HK; Kim, HI; Kim, EH; Jeon, MJ; Yi, HS; Kim, ES; Kim, H; Kim, TH; Kim, BH; Kim, TY; Kang, HC; Kim, WB; Chung, JH; Shon, YK; Kim, SW; Kim, WG

SCI REP-UK 2018 10.1038/s41598-018-31955-9
Modified Bethesda system informing cytopathologic adequacy improves malignancy risk stratification in nodules considered benign or atypia(follicular lesion) of undetermined significance
Lee1, YB; Kim, JY; Cho, H; Hahn, SY; Shin, JH; Lee, SE; Jun, JE; Kim, SW; Chung, JH; Kim, TH; Oh, YL

ORAL ONCOL 2018 10.1016/j.oraloncology.2018.07.002
Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles
Park1, SY; Kim, HI; Choi, JY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, SH; Kim, K; Jeong, JG; Kim, SW; Chung, JH; Kim, TH

BRIT J SURG 2018 10.1002/bjs.10830
Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma
Park1, SY; Kim, HI; Kim, JH; Kim, JS; Oh, YL; Kim, SW; Chung, JH; Jang, HW; Kim, TH

THYROID 2018 10.1089/thy.2017.0550
Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea
Cho1, YY; Kang, MJ; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Nam, JY; Lee, BW; Lee, YH; Chung, JH; Song, SO; Kim, SW

KOREAN JOURNAL OF INTERNAL MEDICINE 2018 10.3904/kjirn.2016.051
Reference intervals of thyroid hormones during pregnancy in Korea, an iodine-replete area
Kim1, HJ; Cho, YY; Kim, SW; Kim, TH; Jang, HW; Lee, SY; Choi, SJ; Roh, CR; Kim, JH; Chung, JH; Oh, SY

ORAL ONCOL 2018 10.1016/j.oraloncology.2018.01.021
Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis
Kim1, HI; Kim, K; Park, SY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, HS; Kim, SW; Kim, TH; Chung, JH

EUR J NUTR 2018 10.1007/s00394-016-1370-2
Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area
Kim1, HJ; Park, HK; Byun, DW; Suh, K; Yoo, MH; Min, YK; Kim, SW; Chung, JH

ANN INTERN MED 2018 10.7326/M17-1398
Antithyroid Drugs and Congenital Malformations A Nationwide Korean Cohort Study
Seo1, GH; Kim, TH; Chung, JH

HISTOPATHOLOGY 2018 10.1111/his.13401
Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma
Kim1, TH; Lee, M; Kwon, AY; Choe, JH; Kim, JH; Kim, JS; Hahn, SY; Shin, JH; Chung, MK; Son, YI; Ki, CS; Yim, HS; Kim, YL; Chung, JH; Kim, SW; Oh, YL

THYROID 2018 10.1089/thy.2017.0356
Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study
Kim1, M; Kim, TH; Shin, DY; Lim, DJ; Kim, EY; Kim, WB; Chung, JH; Shong, YK; Kim, BH; Kim, WG

CLIN ENDOCRINOL 2018 10.1111/cen.13489
Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during long-term follow-up
Sohn1, SY; Kim, HI; Kim, YN; Kim, TH; Kim, W; Chung, JH

PLoS One 2018 10.1371/journal.pone.0190738
Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: Data from Korean National Health and Nutrition Examination Survey IV (2013-2015)
Park1, SY; Kim, HI; Oh, HK; Kim, TH; Jang, HW; Chung, JH; Shin, MH; Kim, SW

J CLIN ENDOCR METAB 2018 10.1210/jc.2017-01775
High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance
Kim1, HI; Jang, HW; Ahn, HS; Ahn, S; Park, SY; Oh, YL; Hahn, SY; Shin, JH; Kim, JH; Kim, JS; Chung, JH; Kim, TH; Kim, SW

BRIT J SURG 2018 10.1002/bjs.10655
Surgeon volume and prognosis of patients with advanced papillary thyroid cancer and lateral nodal metastasis
Kim1, HI; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Kim, YN; Kim, H; Kim, SW; Chung, JH

Oncoimmunology 2018 10.1080/2162402X.2017.1375642
Development of thyroid dysfunction is associated with clinical response to PD-1 blockade treatment in patients with advanced non-small cell lung cancer
Kim1, HI; Kim, M; Lee, SH; Park, SY; Kim, YN; Kim, H; Jeon, MJ; Kim, TY; Kim, SW; Kim, WB; Kim, SW; Lee, DH; Park, K; Ahn, MJ; Chung, JH; Shong, YK; Kim, WG; Kim, TH

THYROID 2018 10.1089/thy.2017.0214
Practical Initial Risk Stratification Based on Lymph Node Metastases in Pediatric and Adolescent Differentiated Thyroid Cancer
Jeon1, MJ; Kim, YN; Sung, TY; Hong, SJ; Cho, YY; Kim, TY; Shong, YK; Kim, WB; Kim, SW; Chung, JH; Kim, TH; Kim, WG

ONCOTARGET 2017 10.18632/oncotarget.22430
Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations
Hahn1, SY; Kim, TH; Ki, CS; Kim, SW; Ahn, S; Shin, JH; Chung, JH

SCI REP-UK 2017 10.1038/s41598-017-17176-6
Preoperative serum thyroglobulin predicts initial distant metastasis in patients with differentiated thyroid cancer
Kim1, H; Kim, YN; Kim, HI; Park, SY; Choe, JH; Kim, JH; Kim, JS; Chung, JH; Kim, TH; Kim, SW

ENDOCRINE 2017 10.1007/s12020-017-1381-7
Validation of dynamic risk stratification in pediatric differentiated thyroid cancer
Sohn1, SY; Kim, YN; Kim, HI; Kim, TH; Kim, SW; Chung, JH

Cancer Med 2017 10.1002/cam4.1160
Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size
Kim1, HI; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Jang, HW; Kim, YN; Kim, H; Ahn, HS; Kim, K; Kim, SW; Chung, JH

ENDOCRINE 2017 10.1007/s12020-017-1363-9
Hormetic effect of triiodothyronine in metabolically healthy obese persons
Jun1, JE; Kim, TH; Lee, SE; Lee, YB; Jee, JH; Bae, JC; Jin, SM; Hur, KY; Kim, JH; Kim, SW; Chung, JH; Min, YK; Lee, MK

CLIN ENDOCRINOL 2017 10.1111/cen.13344
Delayed TSH recovery after dose adjustment during TSH-suppressive levothyroxine therapy of thyroid cancer
Kim1, HI; Kim, TH; Kim, H; Kim, YN; Jang, HW; Kim, JH; Hur, KY; Chung, JH; Kim, SW

ORAL ONCOL 2017 10.1016/j.oraloncology.2017.06.004
Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma
Kim1, TH; Kim, YN; Kim, HI; Park, SY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Kim, K; Jeong, JG; Kim, SW; Chung, JH

ENDOCRINE 2017 10.1007/s12020-017-1340-3
Ultrasonographic prediction of highly aggressive telomerase reverse transcriptase (TERT) promoter-mutated papillary thyroid cancer
Kim1, TH; Ki, CS; Hahn, SY; Oh, YL; Jang, HW; Kim, SW; Chung, JH; Shin, JH

THYROID 2017 10.1089/thy.2016.0648
Patterns of Initial Recurrence in Completely Resected Papillary Thyroid Carcinoma
Kim1, H; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Chi, SA; Jung, SH; Kim, YN; Kim, HI; Kim, SW; Chung, JH

PLoS One 2017 10.1371/journal.pone.0182090
Subclinical thyroid dysfunction and risk of carotid atherosclerosis
Kim1, H; Kim, TH; Kim, HI; Park, SY; Kim, YN; Kim, S; Kim, MJ; Jin, SM; Hur, KY; Kim, JH; Lee, MK; Min, YK; Chung, JH; Kang, M; Kim, SW

Eur J Nutr. 2017 Apr;56(3):965-971. doi: 10.1007/s00394-015-1144-2. Epub 2016 Jan 8.
Strong association of relatively low and extremely excessive iodine intakes with thyroid cancer in an iodine-replete area
Kim HJ11, Kim NK2, Park HK1, Byun DW1, Suh K1, Yoo MH1, Min YK2, Kim SW2, Chung JH3.

Eur J Endocrinol. 2017 Apr;176(4):441-450. doi: 10.1530/EJE-16-0734. Epub 2017 Jan 18.
Association of triiodothyronine levels with future development of metabolic syndrome in euthyroid middle-aged subjects: a 6-year retrospective longitudinal study
Kim HJ11, Bae JC2, Park HK1, Byun DW1, Suh K1, Yoo MH1, Jae Hwan J3, Kim JH4, Min YK4, Kim SW4, Chung JH5.

Osteoporos Int. 2017 Apr;28(4):1377-1384. doi: 10.1007/s00198-016-3892-0. Epub 2017 Feb 10.
Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis
Lee DY11,2, Jee JH3, Cho YY1, Jang JY1, Yu TY1, Kim TH1, Hong YJ1, Hong WJ1, Jin SM1, Hur KY1, Kim JH1, Kim SW1, Chung JH1, Lee MK1, Min YK4.

Clin Endocrinol (Oxf). 2017 Mar;86(3):438-443. doi: 10.1111/cen.13254. Epub 2016 Nov 2.
Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years?
Kim M11, Kim YN2, Kim WG1, Park S1, Kwon H1, Jeon MJ1, Ahn HS3, Jung SH4, Kim SW2, Kim WB1, Chung JH2, Shong YK1, Kim TH2, Kim TY1.

J Clin Endocrinol Metab. 2017 Feb 1;102(2):625-633. doi: 10.1210/jc.2016-2287.
Long-Term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study
Hwangbo Y11,2, Kim JM3, Park YJ2, Lee EK1, Lee YJ1, Park DJ2, Choi YS4, Lee KD5, Sohn SY6, Kim SW6, Chung JH6, Lim DJ7, Kim MH7, Kim MJ3, Jo YS8, Shong MH8, Koong SS9, Hahm JR10, Jung JH10, Yi KH2,11.

Endocrine. 2017 Feb;55(2):503-512. doi: 10.1007/s12020-016-1138-8. Epub 2016 Oct 5.
The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects
Lee DY11,2, Jee JH3, Jun JE1, Kim TH1, Jin SM1, Hur KY1, Kim SW1, Chung JH1, Lee MK1, Kim JH4,5.

Head Neck. 2017 Feb;39(2):269-274. doi: 10.1002/hed.24578. Epub 2016 Sep 12.
Current status and diagnostic values of the Bethesda system for reporting thyroid cytopathology in a papillary thyroid carcinoma-prevalent area
Lee YB11, Cho YY2, Jang JY3, Kim TH1, Jang HW4, Chung JH1, Oh YL5, Kim SW1.

Endocr Relat Cancer. 2017 Feb;24(2):97-106. doi: 10.1530/ERC-16-0421.
Comprehensive screening for PD-L1 expression in thyroid cancer
Ahn S11, Kim TH2, Kim SW2, Ki CS3, Jang HW4, Kim JS5, Kim JH5, Choe JH5, Shin JH6, Hahn SY6, Oh YL7, Chung JH8.

Ann Lab Med. 2017 Jan;37(1):63-65. doi: 10.3343/alm.2017.37.1.63.
First Report of Familial Dysalbuminemic Hyperthyroxinemia With an ALB Variant
Cho YY11,2, Song JS3, Park HD3, Kim YN1, Kim HI1, Kim TH1, Chung JH1, Ki CS4, Kim SW5.

PLoS One. 2017 Jan 12;12(1):e0169775. doi: 10.1371/journal.pone.0169775. eCollection 2017.
Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication
Kim HI11, Kim TH1, Kim H1, Kim YN1, Jang HW2, Chung JH1, Moon SM3, Jhun BW3, Lee H3, Koh WJ3, Kim SW1.

Nutrients. 2016 Dec 8;8(12). pii: E797.
A Prospective Study on Serum Methylmalonic Acid and Homocysteine in Pregnant Women
Choi R11, Choi S2, Lim Y3, Cho YY4, Kim HJ5, Kim SW6, Chung JH7, Oh SY8, Lee SY9.

Nutrients. 2016 Nov 23;8(11). pii: E749.
A Prospective Study of Serum Trace Elements in Healthy Korean Pregnant Women
Choi R11, Sun J2, Yoo H3, Kim S4, Cho YY5, Kim HJ6, Kim SW7, Chung JH8, Oh SY9, Lee SY10,11.

Endocr Relat Cancer. 2016 Oct;23(10):813-23. doi: 10.1530/ERC-16-0219. Epub 2016 Aug 15.
TERT promoter mutations and long-term survival in patients with thyroid cancer
Kim TH11, Kim YE2, Ahn S3, Kim JY4, Ki CS5, Oh YL3, Kim K6, Yun JW7, Park WY7, Choe JH8, Kim JH8, Kim JS8, Kim SW1, Chung JH9.

Head Neck. 2016 Oct;38(10):1501-8. doi: 10.1002/hed.24469. Epub 2016 Apr 7.
Clinical outcomes of patients with hypercalcitoninemia after initial treatment for medullary thyroid cancer and postoperative serum calcitonin cutoffs for predicting structural recurrence
Cho YY11, Jang HW2, Jang JY1, Kim TH1, Choe JH3, Kim JH3, Kim JS3, Kim SW1, Chung JH4.

Ann Lab Med. 2016 Sep;36(5):413-9. doi: 10.3343/alm.2016.36.5.413.
Performance Evaluation of the Serum Thyroglobulin Assays With Immunochemiluminometric Assay and Immunoradiometric Assay for Differentiated Thyroid Cancer
Cho YY11, Chun S2, Lee SY2, Chung JH1, Park HD3, Kim SW4.

Am J Clin Oncol. 2016 Aug;39(4):374-8. doi: 10.1097/COC.0000000000000072.
Efficacy of Low-dose and High-dose Radioactive Iodine Ablation With rhTSH in Korean Patients With Differentiated Thyroid Carcinoma The First Report in Nonwestern Countries
Joung JY11, Choi JH, Cho YY, Kim NK, Sohn SY, Kim SW, Chung JH.

Cancer Med. 2016 May;5(5):769-77. doi: 10.1002/cam4.636. Epub 2016 Jan 18.
Triage of patients with AUS/FLUS on thyroid cytopathology: effectiveness of the multimodal diagnostic techniques
Kim TH11, Jeong DJ1, Hahn SY2, Shin JH2, Oh YL3, Ki CS4, Kim JW4, Jang JY1, Cho YY1, Chung JH1, Kim SW1.

Thyroid. 2016 May;26(5):672-82. doi: 10.1089/thy.2015.0527.
Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer
Sohn SY11, Park WY2,3, Shin HT2, Bae JS2, Ki CS4, Oh YL5, Kim SW6, Chung JH6.

Eur J Nutr. 2016 Mar;55(2):469-75. doi: 10.1007/s00394-015-0864-7. Epub 2015 Mar 7.
Iodine status in healthy pregnant women in Korea: a first report
Cho YY11, Kim HJ1,2, Oh SY3, Choi SJ3, Lee SY4, Joung JY1, Jeong DJ1, Sohn SY1, Chung JH1, Roh CR5, Kim SW6.

Head Neck. 2016 Jan;38(1):159. doi: 10.1002/hed.24208. Epub 2015 Sep 8.
Reply to Letter to the Editor regarding association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma
Kim HJ11, Chung JH2.

PLoS One. 2015 Dec 17;10(12):e0145292. doi: 10.1371/journal.pone.0145292. eCollection 2015.
A Modest Protective Effect of Thyrotropin against Bone Loss Is Associated with Plasma Triiodothyronine Levels
Kim TH11, Joung JY1, Kang M2, Choi SK3, Kim K3, Jang JY1, Cho YY1, Min YK1, Chung JH1, Kim SW1.

PLoS One. 2015 Dec 17;10(12):e0145292. doi: 10.1371/journal.pone.0145292. eCollection 2015.
A Modest Protective Effect of Thyrotropin against Bone Loss Is Associated with Plasma Triiodothyronine Levels
Kim TH11, Joung JY1, Kang M2, Choi SK3, Kim K3, Jang JY1, Cho YY1, Min YK1, Chung JH1, Kim SW1.

Thyroid. 2015 Aug;25(8):927-34. doi: 10.1089/thy.2014.0557. Epub 2015 Jul 2.
Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea
Seo GH11, Cho YY2, Chung JH2, Kim SW2.

Nutrients. 2015 May 11;7(5):3427-48. doi: 10.3390/nu7053427.
High Prevalence of Vitamin D Deficiency in Pregnant Korean Women: The First Trimester and the Winter Season as Risk Factors for Vitamin D Deficiency
Choi R11, Kim S2, Yoo H3, Cho YY4, Kim SW5, Chung JH6, Oh SY7, Lee SY8.

Head Neck. 2015 May;37(5):650-4. doi: 10.1002/hed.23650. Epub 2014 Apr 10.
Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma
Kim HJ11, Park HK, Byun DW, Suh K, Yoo MH, Min YK, Kim SW, Chung JH.

Eur J Clin Nutr. 2015 Mar;69(3):361-6. doi: 10.1038/ejcn.2014.284. Epub 2015 Feb 4.
Effect of high dietary sodium on bone turnover markers and urinary calcium excretion in Korean postmenopausal women with low bone mass
Park SM11, Joung JY1, Cho YY1, Sohn SY1, Hur KY1, Kim JH1, Kim SW1, Chung JH1, Lee MK1, Min YK1.

Endocr J. 2015;62(3):243-50. doi: 10.1507/endocrj.EJ14-0384. Epub 2014 Dec 4.
Diagnostic accuracy of plasma free metanephrines in a seated position compared with 24-hour urinary metanephrines in the investigation of pheochromocytoma
Kim HJ11, Lee JI, Cho YY, Lee SY, Kim JH, Jung BC, Kim SW, Chung JH, Min YK, Lee MS, Lee MK, Kim JH.

Cancer. 2015 Jan 15;121(2):259-68. doi: 10.1002/cncr.29025. Epub 2014 Sep 15.
Elevated Risks of Subsequent Primary Malignancies in Patients With Thyroid Cancer: A Nationwide, Population-Based Study in Korea
Cho YY11, Lim J, Oh CM, Ryu J, Jung KW, Chung JH, Won YJ, Kim SW.

Head Neck. 2014 Dec;36(12):1695-700. doi: 10.1002/hed.23511. Epub 2014 Feb 27.
Association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma
Kim HJ11, Sung JY, Oh YL, Kim JH, Son YI, Min YK, Kim SW, Chung JH.

Thyroid. 2014 Sep;24(9):1361-8. doi: 10.1089/thy.2014.0046. Epub 2014 Jun 30.
Effect of Iodine Restriction on Thyroid Function in Subclinical Hypothyroid Patients in an Iodine-Replete Area: A Long Period Observation in a Large-Scale Cohort
Joung JY11, Cho YY, Park SM, Kim TH, Kim NK, Sohn SY, Kim SW, Chung JH.

J Korean Med Sci. 2014 Aug;29(8):1033-4. doi: 10.3346/jkms.2014.29.8.1033.
Unfounded Reports on Thyroid Cancer
1,Chung JH1.

Asian Pac J Cancer Prev. 2014;15(12):5107-10.
Effectiveness of Ultrasonographic Screening for Thyroid Cancer: Round-table Conference in the National Evidence-based Healthcare Collaborating Agency (NECA) in conjunction with the Korean Thyroid Association
Shin S11, Park SE, Kim SY, Hyun MK, Kim SW, Kwon JW, Kim Y, Kim WB, Na DG, Park HA, Sheen SS, Yi KH, Chang HS, Cho JJ, Chung JH.

Clin Chem Lab Med. 2014 Jul;52(7):e139-42. doi: 10.1515/cclm-2013-1007.
Evaluation of mutation profiling by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry in fine needle aspirations from papillary thyroid cancer
Woo HI1, Kim SW, Ki CS, Shin JH, Oh YL, Kim JW, Chung JH.

Thyroid. 2014 May;24(5):872-7. doi: 10.1089/thy.2013.0238. Epub 2014 Mar 6.
The Impact of Iodinated Contrast Agent Administered During Preoperative Computed Tomography Scan on Body Iodine Pool in Patients with Differentiated Thyroid Cancer Preparing for Radioactive Iodine Treatment
Sohn SY11, Choi JH, Kim NK, Joung JY, Cho YY, Park SM, Kim TH, Jin SM, Bae JC, Lee SY, Chung JH, Kim SW.

Endocrine. 2014 Mar;45(2):256-62. doi: 10.1007/s12020-013-9997-8. Epub 2013 Jul 3.
Role of autophagy in the resistance to tumour necrosis factor-related apoptosis-inducing ligand-induced apoptosis in papillary and anaplastic thyroid cancer cells
Jin SM11, Jang HW, Sohn SY, Kim NK, Joung JY, Cho YY, Kim SW, Chung JH.

Head Neck. 2014 Jan;36(1):43-6. doi: 10.1002/hed.23252. Epub 2013 Jun 1.
Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas
Sohn SY11, Kim HJ, Jang HW, Kim SW, Chung JH.

J Diabetes Investig. 2014 Feb 12;5(1):51-9. doi: 10.1111/jdi.12127. Epub 2013 Sep 2.
Predictive factors of durability to sitagliptin: Slower reduction of glycated hemoglobin, older age and higher baseline glycated hemoglobin
Chung HS11, Suh S2, Kim MY3, Kim SK3, Kim HK3, Lee JI3, Hur KY3, Kim JH3, Min YK3, Lee MS3, Kim KW3, Kim SW3, Chung JH3, Lee MK3.

World J Surg. 2013 Dec;37(12):2845-52. doi: 10.1007/s00268-013-2213-4.
Prognostic Implications of Radioiodine Avidity and Serum Thyroglobulin in Differentiated Thyroid Carcinoma with Distant Metastasis
Kim HJ11, Lee JI, Kim NK, Min YK, Kim SW, Chung JH.

Head Neck. 2013 Apr;35(4):548-53. doi: 10.1002/hed.22997. Epub 2012 Apr 7.
BRAF(V600E) mutation in fine-needle aspiration aspirates: Association with poorer prognostic factors in larger papillary thyroid carcinomas
Lee JI11, Jang HW, Kim SW, Kim JW, Oh YL, Chung JH.

Endocr Res. 2013;38(2):89-97. doi: 10.3109/07435800.2012.723292.
ERK Phosphorylation Is Not Increased in Papillary Thyroid Carcinomas with BRAF(V600E) Mutation Compared to That of Corresponding Normal Thyroid Tissues
Kim SW11, Kim HK, Lee JI, Jang HW, Choe JH, Kim JH, Kim JS, Hur KY, Kim JH, Chung JH.

World J Surg. 2013 Feb;37(2):376-84. doi: 10.1007/s00268-012-1835-2.
Multifocality, But Not Bilaterality, Is a Predictor of Disease Recurrence/Persistence of Papillary Thyroid Carcinoma
Kim HJ11, Sohn SY, Jang HW, Kim SW, Chung JH.

Clin Endocrinol (Oxf). 2012 Sep;77(3):459-64. doi: 10.1111/j.1365-2265.2012.04396.x.
Time trend in tumour size and characteristics of anaplastic thyroid carcinoma
Han JM11, Bae Kim W, Kim TY, Ryu JS, Gong G, Hong SJ, Kim JH, Oh YL, Jang HW, Kim SW, Chung JH, Shong YK.

J Clin Endocrinol Metab. 2012 Jul;97(7):2299-306. doi: 10.1210/jc.2011-3135. Epub 2012 Apr 12.
Clinical Implication of Highly Sensitive Detection of the BRAF V600E Mutation in Fine-Needle Aspirations of Thyroid Nodules: A Comparative Analysis of Three Molecular Assays in 4585 Consecutive Cases in a BRAF V600E Mutation-Prevalent Area
Lee ST11, Kim SW, Ki CS, Jang JH, Shin JH, Oh YL, Kim JW, Chung JH.

Head Neck. 2012 Apr;34(4):599-603. doi: 10.1002/hed.21575. Epub 2010 Nov 12.
Characteristics of Killian-Jamieson diverticula mimicking a thyroid nodule
Kim HK11, Lee JI, Jang HW, Bae SY, Lee JH, Kim YS, Shin JH, Kim SW, Chung JH.

J Korean Med Sci. 2012 Feb;27(2):177-83. doi: 10.3346/jkms.2012.27.2.177. Epub 2012 Jan 27.
The Ability of beta-Cells to Compensate for Insulin Resistance is Restored with a Reduction in Excess Growth Hormone in Korean Acromegalic Patients
Kim SK11, Suh S, Lee JI, Hur KY, Chung JH, Lee MK, Min YK, Kim JH, Kim JH, Kim KW.

Endocr Res. 2011;36(4):149-57. doi: 10.3109/07435800.2011.593012.
Anti-proliferative Effect and Action Mechanism of Dexamethasone in Human Medullary Thyroid Cancer Cell Line
Chung YJ11, Lee JI, Chong S, Seok JW, Park SJ, Jang HW, Kim SW, Chung JH.

Immunol Invest. 2011;40(2):172-82. doi: 10.3109/08820139.2010.525571. Epub 2010 Nov 10.
Identification of HLA-DRB1 Alleles Associated with Graves' Disease in Koreans by Sequence-Based Typing
Jang HW11, Shin HW, Cho HJ, Kim HK, Lee JI, Kim SW, Kim JW, Chung JH.

Endocr J. 2010;57(12):1045-54. Epub 2010 Oct 22.
Localization of medullary thyroid carcinoma after surgery using (HC)-H-11-methionine PET/CT: comparison with F-18-FDG PET/CT
Jang HW11, Choi JY, Lee JI, Kim HK, Shin HW, Shin JH, Kim SW, Chung JH.

J Histochem Cytochem. 2010 Aug;58(8):731-40. doi: 10.1369/jhc.2010.955906. Epub 2010 Apr 26.
Pathologic Changes and Glucose Homeostasis According to Expression of Human Islet Amyloid Polypeptide in Type 2 Diabetic Patients
Park JY11, No HS, Ahn YR, Oh SH, Kim YS, Kim SY, Jang KT, Kim SW, Chung JH, Min YK, Heo JS, Choi SH, Choi DW, Lee MS, Lee MK, Kim JH, Kim KW.

J Clin Endocrinol Metab. 2010 Aug;95(8):3693-700. doi: 10.1210/jc.2009-2795. Epub 2010 May 25.
BRAF(V600E) Mutation Analysis in Fine-Needle Aspiration Cytology Specimens for Evaluation of Thyroid Nodule: A Large Series in a BRAF(V600E)-Prevalent Population
Kim SW11, Lee JI, Kim JW, Ki CS, Oh YL, Choi YL, Shin JH, Kim HK, Jang HW, Chung JH.

J Korean Med Sci. 2010 Feb;25(2):317-20. doi: 10.3346/jkms.2010.25.2.317. Epub 2010 Jan 19.
Autosomal Dominant Hypocalcemia Caused by an Activating Mutation of the Calcium-Sensing Receptor Gene: The First Case Report in Korea
Kim MY11, Tan AH, Ki CS, Lee JI, Jang HW, Shin HW, Kim SW, Min YK, Lee MS, Lee MK, Kim KW, Chung JH.

Endocr J. 2009;56(3):399-405. Epub 2009 Feb 18.
Clinical Characteristics of Primary Thyroid Lymphoma in Koreans
Hwang YC11, Kim TY, Kim WB, Shong YK, Yi KH, Shong M, Jo YS, Kim WS, Chung JH.

J Korean Med Sci. 2009 Feb;24(1):46-51. doi: 10.3346/jkms.2009.24.1.46. Epub 2009 Feb 28.
Comparisons between Macroadenomas and Microadenomas in Cushing's Disease: Characteristics of Hormone Secretion and Clinical Outcomes
Hwang YC11, Chung JH, Min YK, Lee MS, Lee MK, Kim KW.

J Korean Med Sci. 2008 Oct;23(5):870-6. doi: 10.3346/jkms.2008.23.5.870.
Overexpression of USF Increases TGF-beta 1 Protein Levels, But G1 Phase Arrest was not Induced in FRTL-5 Cells
Kim KS11, Jung HS, Chung YJ, Jung TS, Jang HW, Lee MS, Kim KW, Chung JH.

J Korean Med Sci. 2008 Apr;23(2):193-8. doi: 10.3346/jkms.2008.23.2.193.
The associations of total and differential white blood cell counts with obesity, hypertension, dyslipidemia and glucose intolerance in a Korean population
Kim DJ11, Noh JH, Lee BW, Choi YH, Chung JH, Min YK, Lee MS, Lee MK, Kim KW.

Head Neck. 2007 Aug;29(8):765-72.
Prognostic factors for Korean patients with anaplastic thyroid carcinoma
Kim TY11, Kim KW, Jung TS, Kim JM, Kim SW, Chung KW, Kim EY, Gong G, Oh YL, Cho SY, Yi KH, Kim WB, Park do J, Chung JH, Cho BY, Shong YK.

Endocr J. 2007 Apr;54(2):275-85. Epub 2007 Mar 20.
USF inhibits cell proliferation through delay in G2/M phase in FRTL-5 cells
Jung HS11, Kim KS, Chung YJ, Chung HK, Min YK, Lee MS, Lee MK, Kim KW, Chung JH.

Endocr J. 2007 Apr;54(2):265-74. Epub 2007 Mar 20.
Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma
Jung TS11, Kim TY, Kim KW, Oh YL, Park do J, Cho BY, Shong YK, Kim WB, Park YJ, Jung JH, Chung JH.

Thyroid. 2006 Dec;16(12):1251-7.
Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients
Chung YJ11, Lee BW, Kim JY, Jung JH, Min YK, Lee MS, Lee MK, Kim KW, Chung JH.

Thyroid. 2006 Jun;16(6):609-14.
A rare extracellular D631Y germline mutation of the RET proto-oncogene in two Korean families with multiple endocrine neoplasia 2A
Bae SJ11, Kim DJ, Kim JY, Park SY, Choi SH, Song YD, Ki CS, Chung JH.

Thyroid. 2006 May;16(5):461-9.
Well-differentiated epithelial thyroid cancer management in the Asia Pacific region: A report and clinical practice guideline
Sundram F11, Robinson BG, Kung A, Lim-Abrahan MA, Bay NQ, Chuan LK, Chung JH, Huang SM, Hsu LC, Kamaruddin N, Cheah WK, Kim WB, Koong SS, Lin HD, Mangklabruks A, Paz-Pacheco E, Rauff A, Ladenson PW.

Metabolism. 2006 Jan;55(1):135-41.
Insulin secretory defect plays a major role in the development of diabetes in patients with distal pancreatectomy
Lee BW11, Kang HW, Heo JS, Choi SH, Kim SY, Min YK, Chung JH, Lee MK, Lee MS, Kim KW.

Exp Mol Med. 2005 Dec 31;37(6):513-23.
Effective glycemic control achieved by transplanting non-viral cationic liposome-mediated VEGF-transfected islets in streptozotocin-induced diabetic mice
Chae HY11, Lee BW, Oh SH, Ahn YR, Chung JH, Min YK, Lee MS, Lee MK, Kim KW.

Diabetes Res Clin Pract. 2005 Oct;70(1):38-45. Epub 2005 Apr 18.
Heterogeneity of early-onset and ketosis-resistant diabetes in Korean subjects - is it possible to determine cut-off age of early-onset type 2 diabetes
Lee BW11, Kim SY, Kim JY, Cho KY, Chung YJ, Min YK, Chung JH, Lee MK, Lee MS, Kim KW.

J Korean Med Sci. 2005 Aug;20(4):562-5.
Fasting plasma glucose cutoff value for the prediction of future diabetes development: A study of middle-aged Koreans in a health promotion center
Kim DJ11, Cho NH, Noh JH, Kim HJ, Choi YH, Jung JH, Min YK, Lee MS, Lee MK, Kim KW.

Transplantation. 2005 Jun 15;79(11):1568-74.
The favorable outcome of human islet transplantation in Korea: Experiences of 10 autologous transplantations
Lee BW11, Jee JH, Heo JS, Choi SH, Jang KT, Noh JH, Jeong IK, Oh SH, Ahn YR, Chae HY, Min YK, Chung JH, Lee MK, Lee MS, Kim KW.

Thyroid. 2004 Oct;14(10):813-8.
RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A
Chung YJ11, Kim HH, Kim HJ, Min YK, Lee MS, Lee MK, Kim KW, Ki CS, Kim JW, Chung JH.

Thyroid. 2004 Jan;14(1):29-33.
Prevalence, clinical and ultrasonographic characteristics of thyroid incidentalomas
Kang HW11, No JH, Chung JH, Min YK, Lee MS, Lee MK, Yang JH, Kim KW.

Diabetes Res Clin Pract. 2002 May;56(2):107-13.
First human trial of pancreatic islet allo-transplantation in Korea - focus on re-transplantation
Yang TY11, Oh SH, Jeong IK, Seo IA, Oh EY, Kim SJ, Chung JH, Min YK, Lee MS, Lee MK, Kim KW, Do YS, Choo SW.

없음
The stimulatory effect of IL-1 beta on the insulin secretion of rat pancreatic islet is not related with NOS pathway
Diabetes Res Clin Pract. 2001 Mar;51(3):163-71.
The effects of dexamethasone on insulin release and biosynthesis are dependent on the dose and duration of treatment
Jeong IK11, Oh SH, Kim BJ, Chung JH, Min YK, Lee MS, Lee MK, Kim KW.

Thyroid. 2001 Jan;11(1):73-80.
Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases
Hahm JR11, Lee MS, Min YK, Lee MK, Kim KW, Nam SJ, Yang JH, Chung JH.

Thyroid. 1999 Dec;9(12):1237-43.
Detection of RET/PTC oncogene rearrangements in Korean papillary thyroid carcinomas
Chung JH11, Hahm JR, Min YK, Lee MS, Lee MK, Kim KW, Nam SJ, Yang JH, Ree HJ.
상세정보 펼쳐보기
동병원
동일과
LIST
골다공증,칼슘대사이상,갱년기장애,고지혈증
화요일오전
화요일오후
수요일오전
목요일오후
금요일오전
당뇨병,1형당뇨병,부신질환
월요일오전
화요일오전
화요일오후
수요일오전
금요일오전
갑상선질환
월요일오후
수요일오전
금요일오전
당뇨병,뇌하수체질환,고지혈증,비만
월요일오후
수요일오후
목요일오전
목요일오후
금요일오전
당뇨병,1형당뇨병,내분비질환
월요일오후
화요일오전
화요일오후
수요일오전
금요일오후
타병원
동일과
LIST
서울대학교병원
갑상선암,갑상선결절,갑상선기증항진증
서울대학교병원
비만,당뇨병,고지혈증
아주대학교병원
당뇨병,비만,대사증후군,갑상선질환
순천향대학교 서울병원
골다공증,당뇨병,뇌하수체질환,갑상선질환
아주대학교병원
당뇨병,내분비대사질환
서울아산병원
소아내분비,유전대사,성장클리닉,리소좀축적질환클리닉
분당서울대학교병원
당뇨병,임신성당뇨병, 고지혈증
단국대학교병원
당뇨병,갑상선,대사증후군
단국대학교병원
당뇨병,갑상선,골다공증,내분비

자동등록방지
자동등록방지 숫자를 순서대로 입력하세요.
hi
이전글  다음글  목록 글쓰기

본 컨텐츠는 광고영역으로 성예사의 추천 또는 보증의 의미를 가지지 않습니다.